AcquisitionOther
NKGen Biotech, Inc. acquired NKMax Co., Ltd.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
NKGen Biotech, Inc. -> NKMax Co., Ltd. · $16.9 million
To gain full control of global manufacturing infrastructure and intellectual property for cell therapy.
Open source record (SEC) ↗